Last Updated: June 22, 2025    
     

 
 
 
Featured Articles

NIH Study Finds Tecovirimat Was Safe but Did Not Improve Mpox Resolution or Pain

NIH | December 10, 2024

HRSA HIV/AIDS Bureau Update: Special Bulletin 

HIV.gov | September 6, 2024

Lower Dose of Mpox Vaccine Is Safe and Generates Six-Week Antibody Response Equivalent to Standard Regimen

NIH | April 27, 2024

Mpox cases in the US are on the rise as vaccination rates lag and new threats loom

CNN | March 28, 2024

HRSA Mpox Web Page
   
News Updates

Mpox virus transcriptional profiles and host responses in skin lesion swabs among individuals with HIV

Oxford Academic | June 11, 2025

Fourth meeting of the International Health Regulations (2005) Emergency Committee regarding the upsurge of mpox 2024 – Temporary...

WHO | June 9, 2025

Vaccination effectively limits mpox progression: lower efficacy in people living with HIV

i-base | May 27, 2025

Characteristics of the first confirmed case of human infection with mpox virus clade Ib in China

Nature | May 27, 2025

Urological Manifestation of Mpox Virus: A Scoping Review

Dovepress | May 24, 2025

Unusual case of non-sexual Mpox transmission in a heterosexual woman

NIH | May 16, 2025

Mpox Transparency and Accountability for the Global Response

Duke Global Health Innovation Center | May 15, 2025

Public Health Strategies for Mpox

CDC | May 14, 2025

Mpox: Multi-country external situation report

WHO | April 29, 2025

The impact of orthopoxvirus vaccination and Mpox infection on cross-protective immunity: a multicohort observational study

The Lancet | April 28, 2025

A Case of Persistently Positive Mpox PCR for One Year in a Patient with Advanced HIV

Oxford Academic | April 16, 2025

Hospitalization for Severe Mpox Significantly More Likely With HIV Coinfection

IDA | April 16, 2025

Transmission dynamics of the 2022 mpox epidemic in New York City

Nature Medicine | March 25, 2025

UK no longer deems clade 1 mpox 'high consequence'

UM | March 19, 2025

Pathogens associated with contamination in dental clinics: Evaluating emerging threats with a focus on mpox

Research Gate | February 2025

US funding pause impedes mpox response in DR Congo

CIDRAP | February 14, 2025

Interim Clinical Considerations for Use of Vaccine for Mpox Prevention in the United States

CDC | February 14, 2025

Mpox: Scientists offer better understanding of tecovirimat resistance

Medical Xpress | February 12, 2025

Clinical Treatment of Mpox

CDC | January 30, 2025

National Mpox Situation Report

WHO | January 28, 2025

Association of HIV infection and hospitalization among mpox cases

BMC Infectious Diseases - BioMed Central | January 22, 2025

Detailed results from Palm007 study: no clinical impact of tecovirimat against mpox clade 1

EATG | January 7, 2025

Early warning systems for maternal sepsis; Mpox and HIV

One Health Trust | January 6, 2025

Mpox Treatment & Management

Medscape | January 1, 2025

 

 
  2022 Archives 2023 Archives 2024 Archives